Source: Annual Congress 2004 - Clinical pathobiology of airway disorders
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Finsnes, E. Omenaas, G. E. Eide, A. Gulsvik (Bergen, Norway). The clinical utility of exhaled nitric oxide (eNO) in asthma, the first 1,000 patients. Eur Respir J 2004; 24: Suppl. 48, 1952

Member's Comments

No comment yet.

Related content which might interest you: Clinical usefulness of fractional exhaled nitric oxide (FeNO) as a marker of long-term asthma control Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Diagnosing asthma using exhaled nitric oxide (eNO) measurements Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma Year: 2003 Is exhaled nitric oxide (eNO) an indipendent outcome measure in chronic stable asthma? Source: Eur Respir J 2002; 20: Suppl. 38, 196s Year: 2002 Stability of exhaled nitric oxide (FENO) in patients with severe, steroid-dependent asthma Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement Year: 2008 Relationship between exhaled nitric oxide (eNO), atopy and asthma in children. ISAAC-clermont-ferrand Source: Eur Respir J 2001; 18: Suppl. 33, 38s Year: 2001 Fractional exhaled nitric oxide (FeNO) for an early diagnosis of asthma Source: Eur Respir J 2006; 28: Suppl. 50, 677s Year: 2006 Exercise training and exhaled nitric oxide (eNO) in COPD patients of different severity Source: Eur Respir J 2001; 18: Suppl. 33, 222s Year: 2001 Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients Source: Eur Respir J 2008; 31: 539-546 Year: 2008 Exhaled nitric oxide (FeNO) in relation to exacerbation of childhood asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 The oropharyngeal contribution to exhaled nitric oxide (eNO) levels Source: Eur Respir J 2001; 18: Suppl. 33, 460s Year: 2001 Concentration of nitric oxide in exhaled air (eNO) in patients with sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 434s Year: 2002 Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD Source: Breathe, 15 (4) 306; 10.1183/20734735.0268-2019 Year: 2019 Usefulness of fractional exhaled nitric oxide (FeNO) as a marker of asthma control Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 Relationship between exhaled nitric oxide (eNO) and sputum eosinophils in severe asthma Source: Eur Respir J 2004; 24: Suppl. 48, 596s Year: 2004 The influence of spirometry on the level of exhaled nitric oxide in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 569s Year: 2003 Screening with exhaled nitric oxide (ENO) may identify cases with on-going bronchial inflammation but not asthma symptoms Source: Eur Respir J 2001; 18: Suppl. 33, 38s Year: 2001 Exhaled nitric oxide (eNO): an early indicator of asthma relapse in children Source: Eur Respir J 2005; 26: Suppl. 49, 42s Year: 2005 Comparisons for concentration in exhaled nitric oxide between patients with bronchial asthma and COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Exhaled nitric oxide (FENO) in the assessment of the safety of allergen immunotherapy (SIT) in asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 209s Year: 2006 Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children Source: Eur Respir J 2003; 21: 433-438 Year: 2003